Glemark Pharma bags approval for Tretinoin Capsules

27/12/2016 09:57

Glenmark Pharmaceuticals Inc.,USA has been granted final approval by the United States Food & Drug Administration(U.S.FDA) for Tretinoin Capsules,10mg,the generic version of Vesanoid Capsules,10mg,of Hoffmann La Roche,Inc.(which is no longer being marketed in United States).

According to IMS Health sales data for the 12 month period ending October 2016,the Vesanoid Capsules,10 mg market achieved annual sales of approximately USD 22.0 million.

Glenmark’s current portfolio consists of 112 products authorized for distribution in the U.S.marktplace and 63 pending approval with the U.S.FDA.

Meanwhile, shares of the company were trading at Rs 893 apiece, up 0.44 per cent from the previous close at 10:00 hours on BSE.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s